The International Waldenstrom’s Macroglobulinemia Foundation (IWMF)
The International Waldenstrom’s Macroglobulinemia Foundation (IWMF) is a patient-founded and patient-led non-profit organization, comprised of 99% volunteers and represents 32,000 Waldenstrom’s patients worldwide! They want you to know with the IWMF, you are never alone and anyone can become a member. As the IWMF strives to support the lives of those living with this rare cancer, the organization offers critical services to achieve that end.
Condition Awareness & Advocacy
Here is a list of conditions this partner raises awareness and advocacy for:
Resources & Support
Patient Worthy Posts on Waldenstrom Macroglobulinemia
IWMF and PleXus Communications are Teaming up to Help Spread Waldenstrom’s Macroglobulinemia Awareness
The International Waldenstrom’s Macroglobulinemia Foundation (IWMF) has recently announced an exciting new partnership that will help facilitate spreading awareness about Waldenstrom’s macroglobulinemia (WM), a rare
Treatment Options for Waldenstrom’s Macroglobulinemia
Anita Lawson was paying the doctor a visit for her annual checkup in 2003 when she was told something that surprised her: she had anemia.
Reflections on the 2019 IWMF Educational Forum
From Friday, June 7th to Sunday, June 9th, 2019, I had the privilege of attending the 2019 International Waldenstrom’s Macroglobulinemia Foundation Educational Forum. This year,
Waldenstrom’s Macroglobulinemia: A Rare Patient Story
On the weekend of June 7th through 9th, I had the privilege of attending the 2019 International Waldenstrom’s Macroglobulinemia Foundation‘s Annual Educational Forum in Philadelphia,
Saturday Afternoon Live: Dr. Steven Treon’s Presentation at the 2019 IWMF Educational Forum June 8th will be Streamed Online!
The International Waldenstrom’s Macroglobulinemia Foundation (IWMF) is a nonprofit organization founded by patients. Their mission? Support patients currently living with Waldenstrom’s Macroglobulinemia (WM) while simultaneously
Research Updates for Multiple Myeloma and WM!
Dana-Farber Cancer Institute has just announced research updates on multiple myeloma and waldenstrom macroglobulinemia which indicate significant progress in the search for treatments for these
